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ABSTRACT
OBJECTIVE: The objective of this systematic review is to determine whether or not acupuncture is an effective
treatment for patients with Irritable Bowel Syndrome.
STUDY DESIGN: Review of three, English language studies published in 2007, 2009 and 2009.
DATA SOURCES: Randomized, placebo-controlled trials comparing the effects of acupuncture to “sham”
acupuncture in relieving the symptoms of IBS were found using Cochrane Databases.
OUTCOMES MEASURED: Self-reported IBS symptoms: abdominal bloating, discomfort, intestinal gas, stool
consistency, daily activity-related anxiety, diet, sleep, health perception, coping with disease and quality of life.
Outcomes were measured data gathered in patients “symptoms diaries” as well as administration of symptom scales
and questionnaires. Clinical Global Impression Scale was used to measure the patient-perceived severity at baseline
and again at the completion of the treatment. Other scales used in the studies include: The IBS Global Severity
Scale, The IBS Adequate Relief scale, The IBS Quality of Life scale and the Functional Digestive Diseases Quality
of Life Questionnaire.
RESULTS: In the three RCT’s included in this review none found a significant difference in improvement of
symptoms of IBS when comparing the acupuncture treatment group to the “sham” acupuncture control group.
However all patients showed some reduction in symptoms from baseline and significant improvement of symptoms
compared to the “wait list” control group.
CONCLUSION: The results of the RCT’s reviewed demonstrated that patients treated with acupuncture and “sham”
acupuncture experience an improvement in symptoms of IBS. The data however, did not prove enough statistical
significance to claim that acupuncture is more effective in the treatment of IBS versus “sham” acupuncture.
KEYWORDS: IBS, Irritable Bowel Syndrome, Acupuncture
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INTRODUCTION
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder
characterized by recurring symptoms of abdominal pain or discomfort associated with
altered bowel habits such as constipation, diarrhea or both. IBS is a chronic GI disorder
that greatly interferes with the patients’ quality of life and leads to significant healthcare
costs. The current treatments used for IBS are aimed at symptomatic relief and lack the
ability to cover the full spectrum of IBS symptoms. In addition to the lack of efficacy,
the medications used for IBS treatment have potential side effects5. This systematic
review paper used three randomized-controlled trials to evaluate whether acupuncture is
an effective treatment for patients with Irritable Bowel Syndrome.
IBS is a common health problem, which makes it likely for practitioner in all
specialties to have patients who suffer from IBS. According to a community survey of
IBS prevalence, the current point prevalence ranges from 12-30%. IBS is 1.5 to 2 times
more common in women compared to men. It is usually diagnosed in patients under the
age of 50 years old. IBS generates a substantial workload for both primary and
secondary care. It is estimated that only 10-50% of patients experiencing symptoms of
IBS consult their primary care provider. Of those patients 17-30% will require a referral
to a gastroenterology specialist. Leading IBS to account for 20-50% referrals of
gastroenterology clinics6. IBS leads to significant cost for the individual, employer and
health services. The estimated total direct cost per year/person range from $348-$8750.
The total days of missed work range from 8.5-21.6 day/year3.
IBS differs from other GI disorders as it is a functional disorder of gut motility
and there are no anatomical or structural abnormalities present. The exact cause of
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dysfunction in IBS is unknown. The symptoms appear to be caused by motor-sensory
dysfunction or an up-regulation in neural processing between the gut and brain. This
pathway is referred to as the “brain-gut-axis.” GI motility and visceral sensitivity are
exaggerated by luminal and environmental factors including inflammation, gut distention,
bacteria, meals, and stress. Despite common belief IBS is not solely a psychosomatic
disorder. Stress and anxiety do not cause IBS. Rather they are provocative factors,
which invoke an exaggerated neural response on the brain-gut-axis in patients with IBS3.
There is no definitive treatment available for IBS. Most conventional therapies
are aimed at symptomatic relief by altering GI motility and sensory function or CNS
processing. Some common medications include: stimulant laxatives, fiber
supplementation, smooth muscle relaxants/antispasmodics, loperamide, tegaserod, and
antidepressants. RCTs have shown little benefit from lactose restriction, fiber
supplementation and stimulant laxatives3. Conventional therapies can cause significant
side effects if not administered correctly. These therapies only work on one area of
dysfunction and lack the ability to cover the full spectrum of IBS symptoms.
The lack of efficacy had lead up to 43% of patients to seek alternatives and
complementary therapies for the management of IBS symptoms3. Acupuncture is
currently gaining more acceptances in Western medicine however there is no clear
evidence to support acupuncture as an effective treatment for IBS. Acupuncture holds
an end on conventional therapies because the basic principle of TCM is to treat the
underlying root cause of disease and restore balance within the body. Therefore, the use
of acupuncture aims to improve the full range of symptoms in a patient with IBS. TCM
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takes a vary individualized approach to evaluating and treating a patient with makes it
very hard to simplify and standardize treatment plans for randomized control trials1.
OBJECTIVE
The objective of this systematic review is to determine whether or not
acupuncture is an effective treatment for patients with Irritable Bowel Syndrome.
METHODS
The following criteria were used in the selection of the three studies found in this
review. The three studies used in this review were a randomized-controlled trial, a pilot
randomized-control trial and a randomized-placebo controlled trial. The population
included adults, >18 years old, with a diagnosis of IBS based on the ROME II criteria.
The type of intervention was acupuncture treatment over a period of several weeks.
Each study had a fixed protocol of acupuncture points used to treat all patients. Optional
points were also allowed at the discretion of the acupuncturist based on the individual’s
Chinese Medicine diagnosis. The Anastasi study included the use of moxibustion in
addition to acupuncture. Moxibustion, another Chinese Medicine therapy, involves the
burning of a small moxa-pole over the acupuncture point to help stimulate the flow of qi.
The studies used “sham” acupuncture and “wait-list” groups as comparisons to the
acupuncture treatment. The “sham” acupuncture uses “Streitberger” needles that are
identical to traditional acupuncture needles but do not actually penetrate the skin. The
sham points were chosen 2-3 cm from the traditional points to avoid acupressure effects
on the meridians or energy channels. The primary outcomes measured in the studies
were patients’ perception of an improvement in quality of life (QOL) and improvement in
self-reported IBS-related symptoms including abdominal pain/discomfort. Intestinal gas,
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bloating, stool consistency were grouped as secondary outcomes as well as IBS Symptom
Severity Scale and IBS Adequate Relief.
I researched the studies in this review using the Cochrane Database from
December 17, 2009 through February 2010. I selected the most recent and relevant
articles based on outcomes that would matter most to patients (POEMS). All the studies
were published in peer-reviewed journal and written in the English language. The
following keywords were used: Irritable Bowel Syndrome, IBS, and Acupuncture.
Inclusion criteria for this review were RCT studies published after 2006 and studies with
outcomes that would be important to patients with IBS. Excluded from this review were
studies that were in previous systematic reviews (Meta Analysis from 2008.) Table 1
includes the demographics and characteristics of the included studies. The statistics
utilized in the studies were p-values, relative benefit increase (RBI), absolute benefit
increase (ABI), and numbers needed to treat (NNT).
OUTCOMES MEASURED
The outcomes in Anastasi’s study include participants’ self-reported IBS
symptoms in “symptom diaries.” Abdominal pain and discomfort were primary
outcomes measured. Secondary outcomes include intestinal gas, bloating, and stool
consistency. The Clinical Global Impression Scale (CGIS) was used to measure the
patient-perceived severity symptoms with a 7-point Likert-type scale. The CGIS was
administered at baseline and again after the completion of a 4-week of treatment.
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Table 1 - Demographics & Characteristics of included studies
Study Typ #Pt Age Inclusion
Exclusion
W
e
s
Criteria
Criteria
/
D
Anasta Pilot 29
18- Sx >6mo
Hx of lactose
2
si,
RCT
70
Based on
intolerance,
2009
yo
Rome
abdominal
Criteria, Dx surgery(except
confirmed
appendix, uterus or
by medical
GB ); GI/GU,gyno
provider and pathology.
absence of
Iron supp.,
pathology
Abx,narcs,bile
acid sequestering,
&stool/gut motility
altering agents
>3d/wk,
Acupuncture w/in
6mos
Lembo RCT 262 >18 Pt met
Received
3
,
yo
Rome II
acupuncture
2
2009
criteria from earlier, abdominal
IBS, Dx
surgery(excluding
confirmed
cholecystectomy,
by GI
appendectomy,
specialist, pt hysterectomy,
allowed to
hernia repair) narc
continue
or other pain meds
IBS meds,
but ask not
to change
dose
Schnei Ran 43
Me Met Rome
insufficient
9
der,
domi
an
II criteria
diagnostic work2007
zed,
age
up, AC tx within
plac
41the last 3 mo, 5ebo
46y
HT3 antagonists
contr
o
and spasmolytics
olled
or pregnant
trial

Interventions
4 weeks of 1hour, twiceweekly treatments
of acupuncture
with moxibustion
or sham
acupuncture(contr
ol)

3 wk “run-in”
w/Sham AC in
“augmented” or
“limited” pt-dr
interaction. After
3 wk blinded rerandomized to
either continue
“Sham” or start
“true” AC. A 3rd
arm, “wait-list”
never received
treatment.
Pt w IBS reived
Acupuncture or
shamacupuncture(streit
berger needles)
for a total of 10
sessions, twice a
week for a total of
5 wks
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In the Schneider trial the outcomes addressed were the symptomatic
improvements in IBS as a result of acupuncture. Symptoms include daily activity-related
anxiety, diet, sleep, discomfort, health perception, coping with disease, and impact of
stress. The outcomes were measured by patients completing Quality of Life (QoL)
questionnaire and assessed using the functional quality of like diseases quality of life
questionnaire (FDDQL).
The outcomes measured in the Lembo study included participants perception of
global improvement in symptoms of IBS. The primary endpoint of the study utilized the
IBS Global Improvement Scale (IBS-GIS). Secondary outcomes were measured using
IBS Symptom Severity Scale (IBS-SSS), the IBS Adequate Relief (IBS-AR), and the IBS
Quality of Life (IBS-QOL).
RESULTS
The primary outcome measured in all three studies pertained to the overall
improvement in patient-perceived symptoms of IBS. Each study used a different scale to
measure the participants’ improvement of symptoms from baseline to the completion of
the study. Table 2 lists the studies with measurements scales used in their respective
study. Table 2 also describes the change in symptoms between the treatment and control
groups. In addition to the comparison of baseline and post-treatment results, table also
included the “between group differences.” This information is important to note because
although none of the studies showed a statistically significant improvement when
comparing the acupuncture group to the “sham” acupuncture group, all participants
showed some improvement in symptoms from baseline.
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In the Lembo study a wait-list control group was also used in addition to the
acupuncture and “sham” acupuncture group. There was no statistically significant
difference in IBS-GIS between the acupuncture treatment group vs. the sham acupuncture
group with a p-value=0.25. However, there was a significant improvement after 3 weeks
of treatment when comparing the acupuncture and sham acupuncture groups to the waitlist group p-value<0.001.
In Anastasi’s 4-week study, the difference in improvements between the
acupuncture group and the sham group was not statistically significant based on a pvalue=0.77. However, both groups experience some reduction in symptom score which
was the primary outcome being measured. The CGIS (measurement of patient-perceived
IBS symptoms) improved during the 4-week study from 3.86(95% CI 3.51-4.20) to
2.08(95% CI 1.27-2.90) in the acupuncture treatment group and from 3.73(95%CI 3.374.09) to 1.73 (95%CI 0.96-2.51) for the sham-acupuncture group.
According to the Schneider study, based on the FDDQL (functional quality of like
diseases quality of life questionnaire) scores, there was a significant increase in the
Quality of Life for IBS patients receiving acupuncture and sham acupuncture p-value
<0.001. However, there is no significant difference in the extent of improvement in
symptoms after the 5-week intervention between the two treatment groups based on pvalue=0.327.
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Table 2. Summary of Improvement of Symptoms of IBS When Treatment with
Acupuncture is Compared with Sham-Acupuncture from Baseline to Post-treatment
Scales
Study

Types of
measurement
used

Anastasi

Clinical Global AC
Impression
Scale
SAC

Lembo

IBS Global
Improvement
Scale

AC
SAC

32%

%responders:

WL

4%

FDDQL

AC

57.7

64.6

Global scores:

SAC

55.3

60.6

Schneider

Tx
Group

Baseline
Scale
scores

Post
treatment

Pvalue

Betweengroup tx
difference

3.86(3.51
-4.20)
3.73
(3.374.09)
*

2.08(1.272.90)
1.73(0.962.51)

<0.05

P=0.77

41%

=0.25

P<0.001
(comparing
AC&SAC
to the WL)

=.001

P=0.327

AC=acupuncture treatment group
SAC=sham-acupuncture treatment group
WL=wait-listed group

Two studies used in this review presented data in dichotomous format which
allowed for further calculations including Relative Benefit Increase (RBI); Absolute
Benefit Increase (ABI); and Numbers Needed to Treat (NNT). Number Needed to Harm
(NNH) was not of interest in this review because of the relative low incidence of adverse
events due to treatment with acupuncture. One study mentioned reports of foot cramps,
nausea and hip pain, all of which were ruled out of being related to the study procedure.
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The lack of any serious side effects suggests that acupuncture is a relatively safe
treatment.

Table 3 reflects the ABI, RBI and NNT from the Lembo and Anastasi

studies which both show a modest benefit increase from acupuncture treatment. Based
on the NNT from these to studies, 10 to 12 patients would need to be treated with
acupuncture for one to have an improvement in symptoms. The 3 studies totaled 334
patients, only 39 of which were lost to follow up. Most were reportedly due to time
constraints.
Table 3. Analysis of Outcomes and NNT in order to Improve the Symptoms in
IBS Patients Treated with Acupuncture v.s Sham-Acupuncture
Study
#completed the RBI
ABI
NNT
study
Anastasi
27
30%
10%
10
Lembo
230
28%
9%
12
Schneider
34
*
*
*

DISCUSSION
There was great amount heterogeneity between the trials including method of
intervention (length of trial and style of acupuncture), controls used, and outcomes
measured. The trials ranged in length from 4-6 weeks which may not have been enough
time to see results from treatment. Acupuncture is traditionally based on individual
assessment that makes it hard to replicate in the structured setting of a randomized
controlled study. A confounding variable in this type of study could be “handling” which
is a result of the innate increase in doctor-patient interaction. In both the acupuncture and
sham-acupuncture group it is difficult to control for the interaction between the provider
and patient that may offer some therapeutic effect to the patient.
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Although the efficacy of acupuncture remains up for debate, the safety of
acupuncture surpasses the risks associated with other medical treatments used for IBS.
None of the studies in this review reported dropout due to adverse effects from the
treatment. However, the time commitment required for acupuncture treatment did lead to
a number of participants withdrawing from the study. It was mentioned in the results
section that ten to twelve patients needs to be treated in order for one patient to benefit
from acupuncture treatment. Although it may seem like a waste of time for the 9
patients who may not have benefitted from acupuncture it should be noted that there was
minimal risk for them participating in the treatment. The same cannot be said about
medical treatments used for IBS management, many of which have multiple side effects.
Patients demand for alternative therapies continues to drive research on acupuncture as
well as reimbursement from insurance companies.
CONCLUSION
The studies reviewed do not statistically support acupuncture as an effective
treatment for IBS. However, at this time no recommendations should be made against
acupuncture because an improvement in symptoms was seen across all trials. More high
quality trials are necessary to make recommendations on the use of acupuncture in IBS.
Future trials should seek alternate control groups other than “sham”-acupuncture. Some
studies on “sham”-acupuncture have suggested that the “Streitberger” needles used can
have some physiological or analgesic effect. There are meridians (or acupuncture points)
at almost every area of the skin and the needle does not have to puncture the skin to
have energetic effects. This may be why there is a lack of difference between the two
groups. There is no way to validate that “sham” acupuncture did not have “true”
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acupuncture effects. The studies did not use Traditional Chinese Medicine (TCM)
diagnoses that are typically used for acupuncture treatments. It is essential in future
studies involving TCM therapy, such as acupuncture, to use a TCM approach for the
evaluation of the patient. These studies lacked individual diagnosis and lack of specified
techniques based on the diagnosis, which is the typical nature of TCM. Also researchers
should use standard outcome measurements such as FDDQL or IBS-QoL to evaluate the
treatments for IBS. It is difficult to compile data from multiple sources when each study
has it own method for evaluating the treatment.
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